Mektovi
Analogs of Mektovi
Find cheaper analogs and generic equivalents for Mektovi.
Active Ingredient: binimetinib
Product Overview
About Mektovi
Mektovi is a prescription medicine that should be started and supervised by a doctor experienced in using cancer medicines.
What it is used for
There is no information available on what Mektovi is used for.
How it is used
Mektovi is available as tablets taken by mouth twice daily. The dose may be reduced or treatment may be stopped temporarily or discontinued if the patient experiences severe side effects. The dose of the other medicine, encorafenib, may also have to be reduced or treatment may have to be temporarily stopped or discontinued, in which case Mektovi should be stopped too. Treatment with Mektovi can last for as long as the patient benefits from it and does not have unacceptable side effects.
How it works
In cancers with the BRAF V600 mutation, an abnormal form of the protein BRAF is present, which switches on another protein called MEK involved in stimulating cell division. This encourages cancers to develop by allowing uncontrolled division of cells. The active substance in Mektovi, binimetinib, works by blocking MEK directly and by preventing its activation by BRAF thereby slowing down the growth and spread of the cancer.
Active substance: binimetinib
Visitor ratings
Help others by rating how useful this product page is.
No ratings yet — be the first.
